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Abstract. 	Preeclampsia	 is	a	systemic	disease	caused	by	abnormal	placentation	 that	affects	both	mother	and	fetus.	 It	was	
reported that Laeverin (LVRN,	also	known	as	Aminopeptidase	Q)	was	up-regulated	in	the	placenta	of	preeclamptic	patients.	
However,	physiological	and	pathological	functions	of	LVRN	remained	to	be	unknown.	Here	we	characterized	Lvrn	function	
during	placentation	in	mice.	RT-PCR	showed	that	Lvrn	is	expressed	in	both	fetus	and	placenta	during	embryogenesis,	and	




not	affected,	and	both	placentas	and	fetuses	grew	normally.	Collectively,	 these	results	suggest	 that,	LVRN	is	 irrelevant	 to	
preeclampsia	and	dispensable	for	normal	placentation	and	embryonic	development	in	mice.
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Fig. 2.	 Analysis	 of	 placenta-specific	 Lvrn	 overexpression	 mice.	 (A)	
Blood	pressures	of	 recipients	with	embryos	 transduced	with	8.0	
×	103	ng/ml	of	LV-Egfp	or	LV-Lvrn.	Systolic	and	diastolic	blood	
pressures	are	 indicated	with	solid	and	dotted	 lines,	 respectively.	
Each	 point	 and	 bar	 represent	 average	 and	 standard	 deviation,	
respectively.	 (B)	Fetal	 and	placental	weights	of	LV-Egfp	or	LV-
Lvrn	 (8.0	×	103	ng/ml)	 transduced	embryos	 recovered	at	E18.5.	
Each	bar	represents	the	average	and	standard	deviation.	(C)	Left,	
hematoxylin-eosin	 staining	 of	 LV-transduced	 placental	 sections.	
Dotted	 line	 demarcates	 the	 labyrinth	 zone	 (LZ)	 and	 junctional	
zone	 (JZ).	Right,	magnified	 images	of	 boxed	 area	 in	 left.	Scale	
Bars,	 300	 μm	 (Left),	 100	 μm	 (Right).	 (D)	 Immunofluorescent	
staining	 of	 CK8	 in	 LV-Egfp	 or	 LV-Lvrn	 transduced	 placentas.	
Asterisk,	Maternal	 blood	 sinus.	 F,	 fetal	 side,	M,	Maternal	 side,	
Scale	Bar,	100	μm.
Fig. 1.	 Generation	 of	 lentiviral	 vector-mediated	 placenta-specific	 Lvrn 





was	 used	 as	 a	 positive	 control	 (28	 cycles).	 E:	 Embryonic	 day,	




(C)	 Detection	 of	 the	 integrated	 lentiviral	 genome	 by	 genomic	
PCR.	 Integration	 of	 LV-Lvrn	 or	 LV-Egfp	 was	 detected	 with	
specific	primers	for	each	lentivirus.	(D)	Immunoblot	detection	of	
LVRN	and	EGFP	protein	 expression	 in	LV-transduced	 embryos	
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